BioCentury
ARTICLE | Clinical News

Genasense oblimersen: Phase I/II

June 30, 2003 7:00 AM UTC

The National Cancer Institute began a U.S. Phase I/II trial of Genasense in 35 patients with Waldenstrom's macroglobulinemia, a disease of malignant plasma cells that is related to multiple myeloma. ...